PDCD1 and primary central nervous system lymphoma: Although PD-1/ programmed death ligand 1 (PD-L1) over-expression in the micro-environment of PCNSL suggested a therapeutic recommendation, the therapeutic response and prognostic correlation was inconclusive [18–20].